“Targeted Next-Generation Sequencing Reveals Increased Incidence of Somatic Myeloid Mutations in Pediatric Systemic Mastocytosis”, presented by Irina Maric, MD, PhD, National Institutes of Health, Bethesda, MD, USA. 2024 AIM Physician & Investigator Conference, Session 2: Pathology & Molecular Biology, Boston, MA. May 18 & 19, 2024.
“TNFa as Major Mast Cell Soluble Cytokine”, presented by Gregor Hoermann, PhD, Munich Leukemia Laboratory, Munich, Germany. 2024 AIM Physician & Investigator Conference, Session 1: Research Updates in Mast Cell Biology, Boston, MA. May 18 & 19, 2024.
2024 AIM Conference, Session 1, Presentation by Gregor Hoermann, PhD. Read More ยป
“Mast Cell Lipid Mediators Associated to Th2 Inflammation.” presented by Joshua Boyce, MD, Brigham & Women’s Hospital/ Harvard University. 2024 AIM Physician & Investigator Conference, Session 1: Research Updates in Mast Cell Biology, Boston, MA. May 18 & 19, 2024.
2024 AIM Conference, Session 1, Presentation by Joshua Boyce, MD. Read More ยป
Q&A featuring Celalettin Ustun, MD and Nives Zimmermann, MD (moderators), Ivan Alvarez Twose, MD, Jennifer Nicoloro-SantaBarbara, PhD, and Melody Carter, MD.
“Predictive Algorithms of Systemic Mastocytosis”, presented by Ivan Alvarez Twose, MD, Castilla La Mancha University, Spain. 2024 AIM Physician & Investigator Conference, Session 4: Clinical Heterogeneity in Mast Cell Disease, Boston, MA. May 18 & 19, 2024.
“Transcriptomic and Phenotypic Characterization of Mast Cell Heterogeneity and KIT D816V Inhibition in Systemic Mastocytosis”, presented by Nicole Case, PhD, Harvard University. 2024 AIM Physician & Investigator Conference, Special Session: Oral Abstract Presentations, Boston, MA. May 18 & 19, 2024.
“Selective Depletion of Mast Cells in Mice via Siglec-6 Targeted Nanotherapy” presented by Chayton H. Rische, PhD, University of Chicago. 2024 AIM Physician & Investigator Conference Special Session: Oral Abstract Presentations, Boston, MA. May 18 & 19, 2024.
Case #3 presented by Tara Ballouz, Mayo Clinic, Arizona. 2024 AIM Physician & Investigator Conference, Special Session: Multidisciplinary Interactive Tumor Board, Boston, MA. May 18 & 19, 2024.
“Promoter of Alpha Tryptase and Clinical Impact” presented by Jonathan Lyons, MD, University of California San Diego. 2024 AIM Physician & Investigator Conference, Session 3: Mast Cell Activation & Hereditary Alpha Tryptasemia, Boston, MA. May 18 & 19, 2024.
“Secondary Mast Cell Activation” presented by Matthew Giannetti, MD, Brigham & Women’s Hospital/ Harvard University. 2024 AIM Physician & Investigator Conference, Boston, MA. May 18 & 19, 2024.
